19 November 2021
Australia/Melbourne timezone
Registrations close 17 November 11:59pm AEDT

Webinar Overview

An Introduction to the BRIGHT program of new beamlines at the Australian Synchrotron

 

The Medium Energy X-ray Absorption Spectroscopy Beamlines (MEX-1 & MEX-2)

The MEX-1 and MEX-2 beamlines will offer several capabilities that allow the study of the chemistry, speciation (oxidation state), and distribution of elements within materials. Unlike the current XAS beamline at the Australian Synchrotron that caters for measurements of the heavier metallic elements, the MEX beamlines are able to target the lighter elements (silicon, phosphorus, sulfur, chlorine, potassium, and calcium), as well as transition metal elements. The MEX beamlines have been designed to offer enhanced capabilities for research in a diverse range of areas including health and human biology, agriculture and food science, environmental science, plant physiology and nutrition, material characterisation and advanced catalysts, geology and earth sciences, as well as museum and cultural heritage studies.

 

The Micro-Computed Tomography Beamline (Micro-CT)

Micro-CT beamline will use monochromatic, pink, and white X-ray beams to provide detailed three-dimensional (3D) structures at high spatial resolution (down to 200 nm) for a wide variety of technologically-important samples, materials and biological systems. The beamline will have automated sample handling capabilities, and also operate with a range of imaging modalities, including adsorption and phase-contrast measurements.

 

The Biological Small Angle X-ray Scattering Beamline (BioSAXS)

BioSAXS is a high flux beamline dedicated to perform all types of solution-based small angle X-ray scattering experiments, with applications in biology, chemistry, material sciences, and other research fields. The endstation will have automated sample handling capabilities for high-throughput studies, and the very bright beam and low measurement background will enable the study of chemical processes and protein dynamics. 

 

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2)

The ADS-1 and ADS-2 beamlines are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials. These beamlines will be focused on the study of mineral formation and recovery under extreme conditions of temperature and pressure; non-destructive detection of cracking, fractures, textures, strains and deformations in large manufactured objects and engineering materials; and the characterisation and optimisation of energy storage, production and conversion systems such as batteries, fuel cells and thermoelectric materials.

 

The High Performance Macromolecular Crystallography Beamline (MX3)

The MX3 beamline will be our Flagship beamline for extremely challenging and high-impact macromolecular crystallography studies. MX3 will strongly complement our currently operational MX1 (bending magnet based) and MX2 (undulator-based, micro-focused) beamlines, with the smallest and brightest X-ray beam for the study of the most challenging samples. Applications will include studies of very small or weakly diffracting protein crystals, such as membrane proteins or proteins relating to virology, as well as studies that require fragment screening, or assessment of large compound libraries for design of new pharmaceuticals.

 

The Nanoprobe Beamline

The Nanoprobe beamline will focus an intense X-ray beam to the range of 60-300 nm, enabling high-impact nanoscale investigations in a wide range of fields including inorganic biochemistry, minerals and mining, advanced manufacturing, environmental sciences, and cultural heritage and conservation. The nanoprobe will enable elemental mapping for elements heavier than silicon, as well as investigations of the chemical state of elements heavier than chromium. Other forms of microscopy will allow structural features as small as 15 nm to be resolved.

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now

×